LEADER 01307nam  2200361 a 450 
001 9910695712503321
005 20070427142056.0
035   $a(CKB)5470000002372660
035   $a(OCoLC)123768550
035   $a(EXLCZ)995470000002372660
100   $a20070427d2007      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPediatric drug research$b[electronic resource] $estudies conducted under Best Pharmaceuticals for Children Act : report to congressional committees
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2007]
215   $aiii, 48 pages $cdigital, PDF file
300   $aTitle from title screen (viewed on Apr. 26, 2007).
300   $a"March 2007."
300   $aPaper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
300   $a"GAO-07-557."
320   $aIncludes bibliographical references.
517   $aPediatric drug research 
606   $aPediatrics$vFormulae, receipts, prescriptions$xResearch
615  0$aPediatrics$xResearch.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910695712503321
996   $aPediatric drug research$93433197
997   $aUNINA